$VANI News

Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?

Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright

Vivani Medical Inc (NASDAQ:VANI) Reports Q4 2025 Results, Advances Semaglutide Implant to Phase 1

Vivani Medical: Q4 Earnings Snapshot

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Vivani Medical Q4 EPS $(0.09) Beats $(0.10) Estimate.

Vivani Medical shares are trading higher after a Form 4 filing showed its Director purchased 1,575,231 shares at an average price of $1.07 each.

Vivani Medical shares are trading higher after a Form 4 filing showed its Director purchased 1,575,231 shares at an average price of $1.07 each.

Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026

Vivani's Brain Implant Helps Blind Patients See Light And Movement In 6-Year Study

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

Reported Earlier, Vivani Medical Announces Pricing Of 1,689,200 Registered Shares And 1,351,351 Private Placement Shares At $1.48 Per Share

Insiders Rewarded With US$1.9m Addition To Investment As Vivani Medical Stock Hits US$110m

Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026

Insiders hold 43% of Vivani Medical, Inc. (NASDAQ:VANI), and they've been buying recently

Vivani Medical: Q3 Earnings Snapshot

Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results